Literature DB >> 18344061

Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.

Steffen Bohl1, Ralf Wassmuth, Hassan Abdel-Aty, André Rudolph, Daniel Messroghli, Rainer Dietz, Jeanette Schulz-Menger.   

Abstract

BACKGROUND: Late gadolinium-hyperenhancement (LHE) on cardiac magnetic resonance imaging (CMR) has been linked to cardiovascular risk in ischemic and non-ischemic heart disease. We aimed to systematically categorize LHE-patterns in a variety of non-ischemic heart diseases (NIHD) and to explore their relationship with left ventricular (LV) function.
METHODS: In a retrospective database search, 156 patients with NIHD who exhibited LHE on CMR were identified. All images were re-analyzed stepwise. LHE was correlated to LV functional parameters. Cardiac magnetic resonance (CMR) was conducted on 1.5 T scanners.
RESULTS: Typically, LHE spared the subendocardium. Consistent LHE-patterns were observed in myocarditis, hypertrophic and dilated cardiomyopathy and systemic vasculitis. No conclusive LHE-patterns were observed in patients with aortic stenosis, arterial hypertension, lupus erythematosus, sarcoidosis, ventricular arrhythmia and in a mixed subgroup of rare NIHDs. There was no significant relationship between LHE and ejection fraction. There was no correlation between enddiastolic volume and LHE in either myocarditis (P = 0.13) or dilated cardiomyopathy (P = 0.62). LHE was unrelated to LV-mass in aortic stenosis (P = 0.13) and hypertrophic cardiomyopathy (P = 0.38).
CONCLUSIONS: Distinct LHE patterns exist in various NIHDs and their visualization may ultimately aid diagnosis. Unlike in ischemic heart disease, the structure-function relationship does not appear to be strong.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18344061     DOI: 10.1007/s10554-008-9300-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  38 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases.

Authors:  N Maehashi; Y Yokota; A Takarada; S Usuki; S Maeda; H Yoshida; T Sugiyama; H Fukuzaki
Journal:  Jpn Heart J       Date:  1991-01

3.  Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension.

Authors:  Kevin G Blyth; Bjoern A Groenning; Thomas N Martin; John E Foster; Patrick B Mark; Henry J Dargie; Andrew J Peacock
Journal:  Eur Heart J       Date:  2005-05-17       Impact factor: 29.983

4.  Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.

Authors:  Heiko Mahrholdt; Anja Wagner; Claudia C Deluigi; Eva Kispert; Stefan Hager; Gabriel Meinhardt; Holger Vogelsberg; Peter Fritz; Juergen Dippon; C-Thomas Bock; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

5.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

6.  Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio.

Authors:  M Pauschinger; D Knopf; S Petschauer; A Doerner; W Poller; P L Schwimmbeck; U Kühl; H P Schultheiss
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

7.  Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis.

Authors:  K Debl; B Djavidani; S Buchner; C Lipke; W Nitz; S Feuerbach; G Riegger; A Luchner
Journal:  Heart       Date:  2006-04-10       Impact factor: 5.994

8.  Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms.

Authors:  Stefan Hein; Eyal Arnon; Sawa Kostin; Markus Schönburg; Albrecht Elsässer; Victoria Polyakova; Erwin P Bauer; Wolf-Peter Klövekorn; Jutta Schaper
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

9.  Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

Authors:  D H Carr; J Brown; G M Bydder; R E Steiner; H J Weinmann; U Speck; A S Hall; I R Young
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

10.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

View more
  39 in total

Review 1.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

2.  Duchenne muscular dystrophy; a cardiomyopathy that can be prevented?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-01       Impact factor: 2.357

3.  Late gadolinium enhancement in cardiomyopathy.

Authors:  F Alpendurada; D J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2008-05-15       Impact factor: 2.357

Review 4.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

5.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

6.  The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis.

Authors:  Alexander Pfeil; Gabriele Lehmann; Joachim Böttcher; Gunter Wolf; Andreas Hansch
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

7.  Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software.

Authors:  Pavel Goykhman; Puja K Mehta; Megha Agarwal; Chrisandra Shufelt; Piotr J Slomka; Yuching Yang; Yuan Xu; Leslee J Shaw; Daniel S Berman; Noel Bairey Merz; Louise E J Thomson
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

Review 8.  Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI.

Authors:  Ralf Wassmuth
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

9.  The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy.

Authors:  M A G M Olimulder; J van Es; M A Galjee
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

Review 10.  Cardiac imaging techniques for physicians: late enhancement.

Authors:  Peter Kellman; Andrew E Arai
Journal:  J Magn Reson Imaging       Date:  2012-09       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.